Carisma Therapeutics holds annual meeting; all proposals approved by shareholders

Carisma Therapeutics Inc.

Directors John Hohneker, M.D. and Michael Torok elected with 16.7M and 16.0M votes for respectively.
Non-binding advisory say-on-pay proposal approved: 16.7M for, 575K against, 60K abstain.
Ratification of KPMG LLP as independent auditor for FY2024 approved: 24.4M for, 173K against.
Meeting adjourned from June 13 due to technical difficulties; reconvened and completed June 14.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.